Zhong-Yin ZHANG,Maria KONTARIDIS,Li-Fan ZENG,Jianxun WANG
申请号：
US15813729
公开号：
US20180071252A1
申请日:
2017.11.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
